One-time intrathecal triamcinolone acetonide application alters the redox potential in cerebrospinal fluid of progressive multiple sclerosis patients: a pilot study
Introduction: Cerebrospinal fluid analysis may provide insight into the interplay between chronic inflammation and response to treatment. Objectives: To demonstrate the impact of one intrathecal triamcinolone injection on the redox potential and on ascorbyl radical appearance in the cerebrospinal fl...
Main Authors: | Thomas Müller, Thomas Herrling, Sven Lütge, Lutz Lohse, Gabi Öhm, Katinka Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-07-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285616636551 |
Similar Items
-
Biochemical indicators for neuronal regeneration during intrathecal triamcinolone application in multiple sclerosis
by: Thomas Müller, et al.
Published: (2015-01-01) -
Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms
by: Przuntek Horst, et al.
Published: (2004-11-01) -
Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
by: Andreas Hoeflich, et al.
Published: (2020-08-01) -
Repeated Intrathecal Triamcinolone Acetonide Administration in Progressive Multiple Sclerosis: A Review
by: Mazen Abu-Mugheisib, et al.
Published: (2011-01-01) -
Repeat Intrathecal Triamcinolone Acetonide Application Reduces Acute Occurring Painful Dysesthesia in Patients with Relapsing Remitting Multiple Sclerosis
by: Kerstin Hellwig, et al.
Published: (2006-01-01)